Table 1. Bone marrow progenitor colony formation and chimerism in transplant recipients.
Recipient mouse# |
Colony #/105 BM cells |
Chimerism (+3STE)(c) |
|||
---|---|---|---|---|---|
No cytokine |
+3STE(b) | % Donor chimerism |
Recipient CFU# /105 |
Donor CFU# /105 |
|
BRAFV600E BMT(a) | |||||
103 | 0 | 85 | 6.7 | 79.3 | 5.7 |
106 | 9 | 92.5 | 6.7 | 86.3 | 6.2 |
114 | 31 | 42.5 | 53.3 | 19.8 | 22.7 |
118 | 15 | 117.5 | 0 | 117.5 | 0 |
122 | 9 | 80 | 15.4 | 67.7 | 12.3 |
127 | 33.5 | 72.5 | 93.3 | 4.8 | 67.7 |
Average | 16.3 | 81.7 | 29.2 | 62.6 | 19.1 |
Control BMT (a) | |||||
116 | 0 | 165 | 46.7 | 88 | 77 |
124 | 0 | 190 | 26.7 | 139.3 | 50.7 |
128 | 0 | 225 | 53.3 | 105 | 120 |
Average | 0 | 193.3 | 42.2 | 110.8 | 82.6 |
2×106 bone marrow nucleated cells from BRAFV600E or control mice 3 weeks after poly I:C injection were injected into each sublethally (5 Gy) irradiated Rag2−/−γc−/− recipient.
10ng/ml IL-3, 50ng/ml SCF, 100ng/ml TPO and 4U/ml EPO were added in “+3STE” cultures.
Donor chimerism was determined by Braf genotyping of randomly plucked individual colonies developed in “+3STE” cultures, and CFU# of donor or recipient origin was calculated by multiplying total colony numbers by the %chimerism.